Efficacy and safety of nerve growth factor for the treatment of neurological diseases:a meta-analysis of 64 randomized controlled trials involving 6,297 patientsOACSCDCSTPCD
Efficacy and safety of nerve growth factor for the treatment of neurological diseases:a meta-analysis of 64 randomized controlled trials involving 6,297 patients
Meng Zhao;Xiao-yan Li;Chun-ying Xu;Li-ping Zou
Department of Pediatrics, Chinese PLA General Hospital, Beijing, ChinaDepartment of Pediatrics, Chinese PLA General Hospital, Beijing, ChinaDepartment of Pediatrics, Chinese PLA General Hospital, Beijing, ChinaDepartment of Pediatrics, Chinese PLA General Hospital, Beijing, China
nerve regenerationneurological diseasesnerve growth factorrandomized controlled trialsmeta-analysisadverse effectsnerve conduction velocityneural regeneration
nerve regenerationneurological diseasesnerve growth factorrandomized controlled trialsmeta-analysisadverse effectsnerve conduction velocityneural regeneration
《中国神经再生研究(英文版)》 2015 (5)
819-831,13
Funding:This study was financially supported by the National Science and Technology Major Projects for “Major New Drugs Innovation and Development”, No.2012ZX09201-301-005
评论